The FDA cleared the investigational new drug application for LTZ-301, a first-in-class myeloid engager immunotherapy, with a ...

FDA clears LTZ's IND application to initiate trial of its myeloid engager immunotherapy to treat relapsed or refractory non-Hodgkin lymphoma.

LTZ-301 is the first asset in the company's platform to enter clinical trials to determine an initial proof of concept for their myeloid engager approach, to foster immunotherapy. LTZ expects to ...

Ltz Therapeutics Inc. has gained IND approval from the FDA for LTZ-301, a first-in-class myeloid engager immunotherapy intended to treat relapsed or refractory non-Hodgkin lymphoma (r/r NHL).

application for LTZ-301, a first-in-class myeloid engager immunotherapy intended to treat relapsed or refractory non-Hodgkin lymphoma (r/r NHL). LTZ-301 is the first asset in the company’s platform to ...

For the second consecutive year, Helight Sleep has been chosen to be part of the prestigious gift bag given to the nominees at the Oscars ceremony. Inspired by NASA research on the circadian rhythm, ...

Nagomi Security introduces its next evolution: a redefined brand, a fully rebuilt website, and expanded platform capabilities designed to help security teams take control of their defenses with ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

Few cars in the light commercial segment look as tough as the 2012 Holden Colorado LTZ. This latest model is a complete rework from the ground up; the result of a two-billion-dollar investment by ...